Arcutis Biotherapeutics Reports Inducement Grants Under Nasd

WESTLAKE VILLAGE, Calif., June 05, 2023 -- Arcutis Biotherapeutics, Inc. , an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in... | June 5, 2023

Related Keywords

Amanda Sheldon , Eric Mcintyre , Globenewswire Inc , Head Of Corporate Communications , Exchange Commission , Arcutis Biotherapeutics Inc , Twitter , Compensation Committee Of Arcuti Board Directors , Nasdaq , Facebook , Compensation Committee , Arcuti Board , Nasdaq Listing Rule , Private Securities Litigation Reform Act , Arcutis Biotherapeutics , Nc Stock Exchange , News , Information , Press Release , Westlake , Pune , 023 , Arcutis , N , Early , Iopharmaceutical , Company , Ocused , Developing , Meaningful , Nnovations Arqt Us03969k1088 ,